Literature DB >> 8395293

Role of neuronal and vascular Ca(2+)-channels in the ACTH-induced reversal of haemorrhagic shock.

S Guarini1, C Bazzani, A Bertolini.   

Abstract

1. In a rat model of volume-controlled haemorrhagic shock causing the death of all control (saline-treated) animals within 30 min, the intravenous (i.v.) bolus injection of ACTH-(1-24) at a dose of 160 micrograms kg-1 produced an impressive and sustained restoration of arterial pressure, pulse pressure and respiratory function, with 100% survival at the end of the observation period (2 h). 2. Both intracerebroventricular (i.c.v., 0.015-0.06 microgram kg-1) and i.v. (5 micrograms kg-1) pretreatment with the N-calcium channel blocker, omega-conotoxin GVIA, and i.v. (but not i.c.v.) pretreatment with the L-calcium channel blocker, nicardipine (125-500 micrograms kg-1) dose-dependently prevented the ACTH-induced shock reversal. 3. These results further indicate that the effect of ACTH in haemorrhagic shock may involve a neuronal link and the eventual restoration of vascular tone mediated by N- and L-type calcium channels, respectively.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8395293      PMCID: PMC2175652          DOI: 10.1111/j.1476-5381.1993.tb13621.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  72 in total

Review 1.  Distribution and functional significance of the P-type, voltage-dependent Ca2+ channels in the mammalian central nervous system.

Authors:  R Llinás; M Sugimori; D E Hillman; B Cherksey
Journal:  Trends Neurosci       Date:  1992-09       Impact factor: 13.837

2.  P-type calcium channels blocked by the spider toxin omega-Aga-IVA.

Authors:  I M Mintz; V J Venema; K M Swiderek; T D Lee; B P Bean; M E Adams
Journal:  Nature       Date:  1992-02-27       Impact factor: 49.962

3.  Evidence for multiple types of Ca2+ channels in acutely isolated hippocampal CA3 neurones of the guinea-pig.

Authors:  D J Mogul; A P Fox
Journal:  J Physiol       Date:  1991-02       Impact factor: 5.182

Review 4.  Physiopathology of neuronal voltage-operated calcium channels.

Authors:  E Sher; E Biancardi; M Passafaro; F Clementi
Journal:  FASEB J       Date:  1991-09       Impact factor: 5.191

5.  Haemorrhagic shock in cardiac surgery. Pharmacological treatment with ACTH (1-24).

Authors:  G Noera; L Angiello; B Biagi; P Pensa
Journal:  Resuscitation       Date:  1991-10       Impact factor: 5.262

6.  Modification of arterial blood pressure in rats following microinjection of drugs into the posterior hypothalamus.

Authors:  H E Brezenoff; D J Jenden
Journal:  Int J Neuropharmacol       Date:  1969-12

Review 7.  The opiomelanotropinergic neuronal and endocrine systems.

Authors:  T L O'Donohue; D M Dorsa
Journal:  Peptides       Date:  1982 May-Jun       Impact factor: 3.750

Review 8.  Opioids and neuropeptides: mechanisms in circulatory shock.

Authors:  E W Bernton; J B Long; J W Holaday
Journal:  Fed Proc       Date:  1985-02

9.  ACTH increases noradrenaline release in pithed rabbits with electrically stimulated sympathetic outflow.

Authors:  B Szabo; L Hedler; K Lichtwald; K Starke
Journal:  Eur J Pharmacol       Date:  1987-04-29       Impact factor: 4.432

10.  Influence of vagotomy and of atropine on the anti-shock effect of adrenocorticotropin.

Authors:  S Guarini; E Rompianesi; W Ferrari; A Bertolini
Journal:  Neuropeptides       Date:  1986-07       Impact factor: 3.286

View more
  2 in total

Review 1.  Synaptic changes induced by melanocortin signalling.

Authors:  Vanni Caruso; Malin C Lagerström; Pawel K Olszewski; Robert Fredriksson; Helgi B Schiöth
Journal:  Nat Rev Neurosci       Date:  2014-02       Impact factor: 34.870

2.  Influence of ACTH-(1-24) on free radical levels in the blood of haemorrhage-shocked rats: direct ex vivo detection by electron spin resonance spectrometry.

Authors:  S Guarini; C Bazzani; G M Ricigliano; A Bini; A Tomasi; A Bertolini
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.